Harnessing big data and artificial intelligence in transfusion medicine: Opportunities for precision, safety and efficiency
Vox Sanguinis · 2026
DOI: 10.1111/vox.70236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Vox Sanguinis, 2026. Verfasst von Sheharyar Raza und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medical Affairs and Innovation, Canadian Blood Services, Toronto, Canada. Hauptthemen laut MEDLINE: Artificial Intelligence, Big Data, Transfusion Medicine, Blood Transfusion. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: The authors received no specific funding for this work..
Abstract (Originalsprache)
Transfusion medicine generates enormous volumes of data across the vein‐to‐vein continuum, spanning donor characteristics, laboratory testing, component manufacturing, logistics and recipient outcomes. The emergence of big data infrastructures, coupled with artificial intelligence (AI), offers a transformative opportunity to harness this information for safer, more efficient and better personalized transfusion practices. This narrative review outlines current and potential applications of AI and machine learning (ML) at each phase of the big data pipeline in transfusion medicine, including data collection, wrangling and harmonization, validation, feature engineering, analysis, publication and knowledge mobilization. We discuss how AI‐enabled methods—such as natural language processing to extract variables, anomaly detection for product quality, supervised models to predict risks, federated analysis for collaboration, and forecasting algorithms to optimize inventory and logistics—may address longstanding challenges related to data fragmentation, unstructured documentation and labour‐intensive manual validation. We emphasize critical risks and limitations of applying AI to big data analytics and discuss mitigation through robust governance, performance monitoring, fairness audits, cybersecurity measures and transparent human oversight. We end by offering key recommendations and future directions, highlighting that strategic, equitable and ethically sound implementation will be essential to realizing benefits and ensuring trust in an increasingly data‐driven transfusion ecosystem.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Affairs and Innovation, Canadian Blood Services, Toronto, Canada.
- Department of Biostatistics, University of Toronto, Toronto, Ontario, Canada.
- Simmons Cancer Institute, Division of Hematology-Oncology, Department of Internal Medicine, SIU School of Medicine, Springfield, Illinois, USA.
- Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
- Aarhus University, Aarhus, Denmark.
- Department of Biochemistry and Molecular Genetics, University of Colorado Anschutz Medical Campus, Denver, Colorado, USA.
ORCID-Profile: Sheharyar Raza, Angelo D'Alessandro, Brian Custer
Förderung
- The authors received no specific funding for this work.
Zitieren
APA
Raza, S., Goel, R., Erikstrup, C., D'Alessandro, A., Custer, B., Li, N., & ISBT BIG DATA Working Party (2026). Harnessing big data and artificial intelligence in transfusion medicine: Opportunities for precision, safety and efficiency. Vox Sanguinis. https://doi.org/10.1111/vox.70236
Vancouver
Raza S, Goel R, Erikstrup C, D'Alessandro A, Custer B, Li N, et al. Harnessing big data and artificial intelligence in transfusion medicine: Opportunities for precision, safety and efficiency. Vox Sanguinis. 2026. doi:10.1111/vox.70236
BibTeX
@article{Raza2026,
author = {Raza, Sheharyar and Goel, Ruchika and Erikstrup, Christian and D'Alessandro, Angelo and Custer, Brian and Li, Na and ISBT BIG DATA Working Party, ISBT BIG DATA Working Party},
title = {Harnessing big data and artificial intelligence in transfusion medicine: Opportunities for precision, safety and efficiency},
journal = {Vox Sanguinis},
year = {2026},
doi = {10.1111/vox.70236}
}
EUVIMED